806 related articles for article (PubMed ID: 21397863)
1. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization.
Finley LW; Carracedo A; Lee J; Souza A; Egia A; Zhang J; Teruya-Feldstein J; Moreira PI; Cardoso SM; Clish CB; Pandolfi PP; Haigis MC
Cancer Cell; 2011 Mar; 19(3):416-28. PubMed ID: 21397863
[TBL] [Abstract][Full Text] [Related]
2. SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF.
Schumacker PT
Cancer Cell; 2011 Mar; 19(3):299-300. PubMed ID: 21397853
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
[TBL] [Abstract][Full Text] [Related]
4. Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization.
Wei L; Zhou Y; Qiao C; Ni T; Li Z; You Q; Guo Q; Lu N
Cell Death Dis; 2015 Apr; 6(4):e1714. PubMed ID: 25855962
[TBL] [Abstract][Full Text] [Related]
5. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.
Bell EL; Emerling BM; Ricoult SJ; Guarente L
Oncogene; 2011 Jun; 30(26):2986-96. PubMed ID: 21358671
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis.
Haigis MC; Deng CX; Finley LW; Kim HS; Gius D
Cancer Res; 2012 May; 72(10):2468-72. PubMed ID: 22589271
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
[TBL] [Abstract][Full Text] [Related]
9. SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells.
Cui Y; Qin L; Wu J; Qu X; Hou C; Sun W; Li S; Vaughan AT; Li JJ; Liu J
PLoS One; 2015; 10(6):e0129834. PubMed ID: 26121691
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Sirtuin 3 Dictates Glucose Transport to Cardiomyocyte and Sensitizes Pressure Overload-Induced Heart Failure.
Zeng H; He X; Chen JX
J Am Heart Assoc; 2020 Jun; 9(11):e015895. PubMed ID: 32468895
[TBL] [Abstract][Full Text] [Related]
11. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
Dong D; Dong Y; Fu J; Lu S; Yuan C; Xia M; Sun L
Life Sci; 2020 Aug; 255():117846. PubMed ID: 32470451
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
Wang L; Yu Z; Ren S; Song J; Wang J; Du G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603
[TBL] [Abstract][Full Text] [Related]
13. SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis.
Srivastava SP; Li J; Kitada M; Fujita H; Yamada Y; Goodwin JE; Kanasaki K; Koya D
Cell Death Dis; 2018 Sep; 9(10):997. PubMed ID: 30250024
[TBL] [Abstract][Full Text] [Related]
14. SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis.
Liu H; Li S; Liu X; Chen Y; Deng H
J Proteome Res; 2018 Sep; 17(9):3143-3152. PubMed ID: 30095923
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
Chiavarina B; Martinez-Outschoorn UE; Whitaker-Menezes D; Howell A; Tanowitz HB; Pestell RG; Sotgia F; Lisanti MP
Cell Cycle; 2012 Sep; 11(17):3280-9. PubMed ID: 22894905
[TBL] [Abstract][Full Text] [Related]
16. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis.
Kong X; Wang R; Xue Y; Liu X; Zhang H; Chen Y; Fang F; Chang Y
PLoS One; 2010 Jul; 5(7):e11707. PubMed ID: 20661474
[TBL] [Abstract][Full Text] [Related]
18. SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.
Barroso E; Rodríguez-Rodríguez R; Zarei M; Pizarro-Degado J; Planavila A; Palomer X; Villarroya F; Vázquez-Carrera M
Cell Commun Signal; 2020 Sep; 18(1):147. PubMed ID: 32912335
[TBL] [Abstract][Full Text] [Related]
19. Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization.
Lim JH; Luo C; Vazquez F; Puigserver P
Cancer Res; 2014 Jul; 74(13):3535-45. PubMed ID: 24812272
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.
Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J
J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
